Title
Category
Credits
Event date
Cost
  • Primary Brain Tumors
$0.00
Outline:EpidemiologyClassification of gliomasMedical management of brain tumorsStandard therapyNovel therapiesNovel trial designs 
  • Primary Brain Tumors
$0.00
A discussion about primary CNS Lymphoma and its updates
  • Primary Brain Tumors
$0.00
Objectives:Concept of "lower-grade glioma (LGG?)Old nomenclature of low (II) vs. high-grade (III-IV) outdatedTransformational impact of IDH mutation discoveryMolecular neuropathology for tumor classificationRole of surgeryOptimal use/sequencing of RT and chemoChemo alone as initial approachChemoradiation vs RTBest first-line chemoTreatment at progressionOngoing clinical trialsIDHwt LGGs 
  • Primary Brain Tumors
$0.00
Outline:EpidemiologyWhat is "elderly"Treatment ConsiderationsRandomized Trials and What They MeanFuture Directions 
  • Nursing and Allied Health
$0.00
Learning Objectives:Understanding the terminology of survivorship, concern survivor, survivorship care, survivorship care research, and survivorship care plansDescribe how survivorship care is high- quality patient-centered care across the illness trajectoryExplore survivorship care delivery opportunities applicable to all neuro-oncology providers 
  • Nursing and Allied Health
$0.00
A focused discussion of the management of shunt-related complications in adult neuro-oncology.
  • Palliative Care
$0.00
A talk about mood and emotions in patients with primary brain tumors.
  • Neurological Complications
$0.00
Objectives:To describe type and pattern of neurotoxicity encountered in patients treated with checkpoint inhibitors and CAR-T cellsTo define potential biomarkers of immunotherapy associated neurotoxicityTo discuss management considerations of patients with immunotherapy
  • Pediatrics NeuroOnc
$0.00
An overview of medulloblastomas and the clinical implications of translational discoveries
  • Pathology
$0.00
Modern diagnostics of ependymal tumorsThe WHO 2016 classification of CNS tumors regarding ependymal tumors and its limitsDNA methylation profiling, c-IMPACT-NOW updates and the WHO 2021 classification of ependymal tumorsPractical diagnostic approaches in 2021

Pages